| |
FDA Approval Activities for this Drug
Maxidex (dexamethasone ophthalmic suspension), 0.1%, Alcon, NDA 13-422/S-035 CEFEPIME HYDROCHLORIDE (ARGININE FORMULATION) Injection 1GM BASE/VIAL MAXIPIME BRISTOL MYERS SQUIBB
050679 CEFEPIME HYDROCHLORIDE (ARGININE FORMULATION) Injection 2GM BASE/VIAL MAXIPIME BRISTOL MYERS SQUIBB
050679 CEFEPIME HYDROCHLORIDE (ARGININE FORMULATION) Injection 500MG BASE/VIAL MAXIPIME BRISTOL MYERS SQUIBB
For the latest approval information and links for this API, please see the main page.
|